Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"
Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"
Recruiting · NCT04920968 · Registry updated 2025-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL" | CD20-positive Acute Lymphoblastic Leukemia | Recruiting | Phase 2 | 2025-04-24 | NCT04920968 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| KCRI | 14 |
| Maria Sklodowska-Curie National Research Institute of Oncology | 28 |
19 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.